SynthesisFrontiers in pharmacology2022

Efficacy and safety of blinatumomab in children with relapsed/refractory B cell acute lymphoblastic leukemia: A systematic review and meta-analysis.

Bin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.